# Oramed Pharmaceuticals Inc. (ORMP)

> Source: Nexqual · https://nexqual.com/ORMP · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Oramed Pharmaceuticals Inc. (ORMP), nexqual.com/ORMP" · informational, not investment advice.

**Price:** USD 4.18 (+0.97% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 4.14 · day 4.15–4.28 · 52w 2.09–5.47 · market cap $174M · NCM

## Key facts
- Analysts: None (1 analysts), mean target USD 7 (range 7–7).
- Total return with dividends: 1Y +97.5% vs S&P 500 +18.1%; 5Y -79.7% vs S&P 500 +85.1%.
- Next earnings: 2026-11-12, EPS estimate USD 0.43, revenue estimate $0K.

## Analysts
Consensus None, 1 analysts; mean target USD 7 (low 7, high 7).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | +97.5% | -79.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +98.0% | -27.2% |
| Volatility (annualized) | 52.8% | 97.8% |
| Max drawdown | -23.9% (May 2026→Jun 2026) | -93.8% (Nov 2021→Oct 2023) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/ORMP · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt